AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23131367 — intervention group
Group type: EXPERIMENTAL
Intervention: Tango dance
Number of subjects: 97
Study 23131367 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 97
Study 23131367 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 97
Study 19542876 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraoral approach
Number of subjects: 58
Study 19542876 — intervention group
Group type: COMPARATOR
Intervention: Intraoral method
Number of subjects: 58
Study 17321311 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate circumcision
Number of subjects: 4996
Study 17321311 — intervention group
Group type: COMPARATOR
Intervention: Circumcision delayed for 24 months (Control)
Number of subjects: 4996
Study 17321311 — intervention group
Group type: EXPERIMENTAL
Intervention: As-treated analysis
Number of subjects: 4996
Study 17321311 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaplan-Meier time-to-HIV-detection as-treated analysis
Number of subjects: 4996
Study 17321311 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate or severe adverse events
Number of subjects: 4996
Study 15603606 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of video-phones for symptom management
Number of subjects: 320
Study 15603606 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of video-phones for quality of life
Number of subjects: 320
Study 15603606 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of video-phones for cost
Number of subjects: 320
Study 15603606 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of video-phones for readiness to use technology
Number of subjects: 320
Study 12421024 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 g omega-3 fatty acids (Maxigard) twice daily
Number of subjects: 65
Study 12421024 — intervention group
Group type: COMPARATOR
Intervention: Placebo with diabetic diet
Number of subjects: 65
Study 9467537 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (5 mg orally, 30 min before breakfast)
Number of subjects: 16
Study 9467537 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (0.5 microgram/kg) after midodrine
Number of subjects: 16
Study 9467537 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (10 mg)
Number of subjects: 16
Study 9467537 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (1.0 microgram/kg)
Number of subjects: 16
Study 9467537 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of midodrine and octreotide
Number of subjects: 16
Study 8008792 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot cold pressor task
Number of subjects: 0
Study 8008792 — intervention group
Group type: EXPERIMENTAL
Intervention: Forehead cold pressor task
Number of subjects: 0
Study 8008792 — intervention group
Group type: COMPARATOR
Intervention: Non-pain stimulus
Number of subjects: 0
Study 2643356 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 61
Study 2643356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 1089368 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylcarbamazine
Number of subjects: 10
Study 1089368 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31373701 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 50 mg
Number of subjects: 194
Study 31373701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study 31373701 — intervention group
Group type: COMPARATOR
Intervention: Naltrexone and Placebo
Number of subjects: 194
Study 31373701 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in drinking
Number of subjects: 194
Study 28723596 — intervention group
Group type: EXPERIMENTAL
Intervention: Assertiveness group training conducted over 10 sessions
Number of subjects: 48
Study 28723596 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study 25293355 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative microcoil localization
Number of subjects: 60
Study 25293355 — intervention group
Group type: COMPARATOR
Intervention: No localization
Number of subjects: 60
Study 23108628 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (40-80 mg)
Number of subjects: 16
Study 23108628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 21646002 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy to the breast
Number of subjects: 1014
Study 21646002 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking status
Number of subjects: 1014
Study 21646002 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-surgical cosmesis
Number of subjects: 1014
Study 21646002 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative infection requiring antibiotics
Number of subjects: 1014
Study 19635302 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 200 units kg(‐1) d(‐1) for 14 days
Number of subjects: 20
Study 19635302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19635302 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo)
Number of subjects: 20
Study 16987465 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) monotherapy
Number of subjects: 0
Study 16987465 — intervention group
Group type: COMPARATOR
Intervention: Triple therapy
Number of subjects: 0
Study 15173402 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75 g/100 g free phytosterols in gerbil diet
Number of subjects: 33
Study 15173402 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytosterol-enriched tortilla chips providing 1.5 g/d
Number of subjects: 33
Study 15173402 — intervention group
Group type: COMPARATOR
Intervention: Control group with no phytosterols in gerbil diet
Number of subjects: 33
Study 15173402 — intervention group
Group type: COMPARATOR
Intervention: Control group with tortilla chips providing 0 g/d phytosterols
Number of subjects: 33
Study 11420737 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel padded glove
Number of subjects: 6
Study 11420737 — intervention group
Group type: COMPARATOR
Intervention: No glove (control)
Number of subjects: 6
Study 9021621 — intervention group
Group type: EXPERIMENTAL
Intervention: DVA/Seattle Footwear System with cork insole
Number of subjects: 24
Study 9021621 — intervention group
Group type: EXPERIMENTAL
Intervention: DVA/Seattle Footwear System with polyurethane insole
Number of subjects: 24
Study 9021621 — intervention group
Group type: EXPERIMENTAL
Intervention: DVA/Seattle Footwear System
Number of subjects: 24
Study 8099818 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 0
Study 8099818 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 0
Study 8099818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3321313 — intervention group
Group type: EXPERIMENTAL
Intervention: Pondocillin cocoa‐peppermint mixture
Number of subjects: 84
Study 3321313 — intervention group
Group type: EXPERIMENTAL
Intervention: Pondocillin banana mixture
Number of subjects: 84
Study 29649054 — intervention group
Group type: EXPERIMENTAL
Intervention: Textured insole with physical therapy for 6 weeks
Number of subjects: 10
Study 29649054 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy only for 6 weeks
Number of subjects: 10
Study 27987397 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic Amoxicillin‐Clavulanic acid 1.2g every 8h
Number of subjects: 60
Study 27987397 — intervention group
Group type: COMPARATOR
Intervention: Clinically-driven antibiotics
Number of subjects: 60
Study 26185896 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention: Use of stainless steel tableware as meal boxes for each meal during the trial.
Number of subjects: 16
Study 26185896 — intervention group
Group type: COMPARATOR
Intervention: Control: Carrying an empty bag during the trial.
Number of subjects: 16
Study 24167479 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose drink (elevated BGC by approx. 1.5 mmol/l)
Number of subjects: 0
Study 24167479 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink (normal BGC range)
Number of subjects: 0
Study 21951607 — intervention group
Group type: EXPERIMENTAL
Intervention: BMAC (bone marrow-derived stem cells)
Number of subjects: 48
Study 21951607 — intervention group
Group type: COMPARATOR
Intervention: Placebo (peripheral blood)
Number of subjects: 48
Study 21951607 — intervention group
Group type: EXPERIMENTAL
Intervention: BMAC
Number of subjects: 48
Study 21951607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 18504482 — intervention group
Group type: EXPERIMENTAL
Intervention: Random urine protein-creatinine ratio with a cut-off greater than 1.14
Number of subjects: 120
Study 18504482 — intervention group
Group type: COMPARATOR
Intervention: 24-hour urine protein collection (gold standard)
Number of subjects: 120
Study 16582059 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal contact psychotherapy plus usual care
Number of subjects: 216
Study 16582059 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 216
Study 12736280 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose therapy with autologous stem-cell transplant
Number of subjects: 407
Study 12736280 — intervention group
Group type: COMPARATOR
Intervention: Standard conventional-dose combination chemotherapy
Number of subjects: 407
Study 10695838 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram during the first month of treatment
Number of subjects: 150
Study 10695838 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychopharmacological treatment
Number of subjects: 150
Study 10695838 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapists with a high conceptual level (empathetic and reflective listening)
Number of subjects: 150
Study 10695838 — intervention group
Group type: EXPERIMENTAL
Intervention: Matching of patients with the structure of treatment
Number of subjects: 150
Study 10695838 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion of the motivation phase and active treatment phase
Number of subjects: 150
Study 10695838 — intervention group
Group type: EXPERIMENTAL
Intervention: Age below 40
Number of subjects: 150
Study 10695838 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of family and social problems
Number of subjects: 150
Study 9126517 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in epidemiology
Number of subjects: 376
Study 9126517 — intervention group
Group type: EXPERIMENTAL
Intervention: < or = 5 or > or = 20 years seniority
Number of subjects: 376
Study 9126517 — intervention group
Group type: COMPARATOR
Intervention: Interest in local epidemiological surveys
Number of subjects: 376
Study 9126517 — intervention group
Group type: COMPARATOR
Intervention: Previous experience with other surveillance networks
Number of subjects: 376
Study 9126517 — intervention group
Group type: COMPARATOR
Intervention: Computing experience, having a medical secretary, feeling of being a 'public health actor', desire to belong to a GPs' network
Number of subjects: 376
Study 1608318 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 50 micrograms/kg (iv)
Number of subjects: 100
Study 1608318 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.15 mg/kg (iv)
Number of subjects: 100
Study 1608318 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine 0.5 mg/kg (im)
Number of subjects: 100
Study 1608318 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine 1 mg/kg (im)
Number of subjects: 100
Study 1608318 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (iv) control
Number of subjects: 100
Study 3874972 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary Time‐Oriented Record (STOR)
Number of subjects: 514
Study 3874972 — intervention group
Group type: COMPARATOR
Intervention: Standard Medical Record (MR)
Number of subjects: 514
Study 3874972 — intervention group
Group type: COMPARATOR
Intervention: Full paper record option
Number of subjects: 514
Study 30834611 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvenous phrenic nerve stimulation (remedē System)
Number of subjects: 151
Study 29498884 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic ACLR with intact menisci
Number of subjects: 49
Study 29498884 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic ACLR with medial meniscal tears
Number of subjects: 49
Study 29498884 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomic ACLR with lateral meniscal tears
Number of subjects: 49
Study 26920611 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blocker therapy (various types including carvedilol, metoprolol succinate, bisoprolol, atenolol, metoprolol tartrate)
Number of subjects: 10696
Study 26920611 — intervention group
Group type: COMPARATOR
Intervention: No β-blocker therapy
Number of subjects: 10696
Study 26920611 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients discharged on 50% of target dose or greater
Number of subjects: 10696
Study 25174952 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nicorandil 20 mg once daily for 1 week before and 6 months after PCI
Number of subjects: 100
Study 25174952 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23025138 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary reconditioning program
Number of subjects: 33
Study 23025138 — intervention group
Group type: COMPARATOR
Intervention: Current standard of care for low back pain
Number of subjects: 33
Study 20958143 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine solution for inhalation (LSI; 40 mg twice daily; eFlow nebulizer)
Number of subjects: 268
Study 20958143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study 17333313 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjectively pleasant music
Number of subjects: 29
Study 17333313 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad music
Number of subjects: 29
Study 17333313 — intervention group
Group type: COMPARATOR
Intervention: White noise
Number of subjects: 29
Study 15895330 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing shoes with 1.5-in high heels
Number of subjects: 49
Study 15895330 — intervention group
Group type: COMPARATOR
Intervention: Control shoes without any additional heel
Number of subjects: 49
Study 17413092 — intervention group
Group type: EXPERIMENTAL
Intervention: High physical activity (HPA) treatment with a goal of 2500 kcal/wk
Number of subjects: 202
Study 17413092 — intervention group
Group type: COMPARATOR
Intervention: Standard behavioral treatment (SBT) with an exercise goal of 1000 kcal/wk
Number of subjects: 202
Study 17413092 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants sustaining high exercise levels (>2500 kcal/wk)
Number of subjects: 202
Study 17413092 — intervention group
Group type: COMPARATOR
Intervention: Participants exercising less than 2500 kcal/wk
Number of subjects: 202
Study 10831015 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (RP)
Number of subjects: 184
Study 10831015 — intervention group
Group type: COMPARATOR
Intervention: Conventional neuroleptics (CNs)
Number of subjects: 184
Study 8842574 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (80% of 1-RM for 7 repetitions, 3 days/week for 52 weeks)
Number of subjects: 0
Study 8842574 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training (40% of 1-RM for 14 repetitions, 3 days/week for 52 weeks)
Number of subjects: 0
Study 8842574 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specified intervention)
Number of subjects: 0
Study 8842574 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training
Number of subjects: 0
Study 8842574 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training
Number of subjects: 0
Study 8842574 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 1538178 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresed morphine HCl
Number of subjects: 38
Study 1538178 — intervention group
Group type: COMPARATOR
Intervention: Iontophoresed lactated ringers solution
Number of subjects: 38
Study 6434024 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral plus nasal beclomethasone diproprionate
Number of subjects: 26
Study 6434024 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 30227772 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting balloon
Number of subjects: 132
Study 30227772 — intervention group
Group type: COMPARATOR
Intervention: Sham (uncoated balloon)
Number of subjects: 132
Study 29752853 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 mcg kg‐1
Number of subjects: 60
Study 29752853 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution (control)
Number of subjects: 60
Study 26350351 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin 10.8 mg (3-monthly)
Number of subjects: 222
Study 26350351 — intervention group
Group type: COMPARATOR
Intervention: Goserelin 3.6 mg (monthly)
Number of subjects: 222
Study 24660763 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonyl iron (45 mg daily)
Number of subjects: 282
Study 24660763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 22153875 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical plus simulator training (group 1, n = 10)
Number of subjects: 28
Study 22153875 — intervention group
Group type: COMPARATOR
Intervention: Simulator training only (group 3, n = 9)
Number of subjects: 28
Study 22153875 — intervention group
Group type: COMPARATOR
Intervention: Clinical training only (group 2, n = 9)
Number of subjects: 28
Study 22153875 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 28
Study 22153875 — intervention group
Group type: COMPARATOR
Intervention: Group 1 vs Group 3
Number of subjects: 28
Study 19884264 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg daily for 12 months
Number of subjects: 198
Study 19884264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 198
Study 18020541 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal drug delivery system (TDDS) of metoprolol tartrate applied for 48 hours
Number of subjects: 0
Study 18020541 — intervention group
Group type: COMPARATOR
Intervention: Conventional marketed tablet of metoprolol tartrate (100 mg)
Number of subjects: 0
Study 18020541 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal drug delivery system (TDDS) of metoprolol tartrate
Number of subjects: 0
Study 16173330 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Intervention (EI)
Number of subjects: 242
Study 16173330 — intervention group
Group type: COMPARATOR
Intervention: Standard Intervention (SI)
Number of subjects: 242
Study 12474653 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) used as an adjuvant to anesthetics; shock-dose injection of 30-50 mg/kg and continual infusion at 500 mg/h for 20 hours.
Number of subjects: 20
Study 10631832 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipivefrine 0.1%
Number of subjects: 40
Study 10631832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7722125 — intervention group
Group type: COMPARATOR
Intervention: Adenosine infusion alone
Number of subjects: 407
Study 7722125 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine with submaximal exercise
Number of subjects: 407
Study 7722125 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom‐limited exercise with continuous adenosine
Number of subjects: 407
Study 30307636 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper cervical mobilisations and neck motor control and stabilisation exercises for 5 weeks
Number of subjects: 61
Study 30307636 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control Group)
Number of subjects: 61
Study 28508455 — intervention group
Group type: COMPARATOR
Intervention: Alpha-blocker only (n=111)
Number of subjects: 221
Study 28508455 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (alpha-blocker + anticholinergic, n=110)
Number of subjects: 221
Study 26507709 — intervention group
Group type: EXPERIMENTAL
Intervention: Timothy grass SLIT tablet
Number of subjects: 1140
Study 26507709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1140
Study 23628617 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide 20 μg
Number of subjects: 495
Study 23628617 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 495
Study 21285132 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant trastuzumab
Number of subjects: 197
Study 21285132 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 197
Study 18392221 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioimmunoscintigraphy (RIS) using monoclonal antibody against human milk fat globule labeled with technetium-99m (99m)Tc
Number of subjects: 74
Study 18392221 — intervention group
Group type: EXPERIMENTAL
Intervention: (99m)Tc-sestamibi ((99m)Tc-S)
Number of subjects: 74
Study 18392221 — intervention group
Group type: EXPERIMENTAL
Intervention: Thallium-201 chloride ((201)TlCl)
Number of subjects: 74
Study 15770636 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component behavior-change intervention
Number of subjects: 267
Study 14534715 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-carotene (75 mg/day for 3-month cycles with one month intercycle intervals for 3 years)
Number of subjects: 214
Study 9890390 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkor Fort (Ginkgo biloba extract, troxerutine, and heptaminol)
Number of subjects: 0
Study 9890390 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8894998 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine air evacuation method (Group 1)
Number of subjects: 42
Study 8894998 — intervention group
Group type: EXPERIMENTAL
Intervention: Air evacuation method controlled with a Doppler ultrasonic probe (Group 2)
Number of subjects: 42
Study 2059815 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg tamoxifen daily and optimal surgery
Number of subjects: 381
Study 2059815 — intervention group
Group type: COMPARATOR
Intervention: tamoxifen alone
Number of subjects: 381
Study 6735044 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelox (shielding antacid) after 500 mg of AAS
Number of subjects: 12